[HTML][HTML] Glycolysis in the control of blood glucose homeostasis

X Guo, H Li, H Xu, S Woo, H Dong, F Lu… - … Pharmaceutica Sinica B, 2012 - Elsevier
Glycolysis, a simple pathway of glucose metabolism, critically regulates insulin secretion
and metabolic functions of various cells. Depending on cell types, rates of glycolysis are …

Metformin and metabolic diseases: a focus on hepatic aspects

J Zheng, SL Woo, X Hu, R Botchlett, L Chen, Y Huo… - Frontiers of …, 2015 - Springer
Metformin has been widely used as a first-line anti-diabetic medicine for the treatment of
type 2 diabetes (T2D). As a drug that primarily targets the liver, metformin suppresses …

Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice

X Luo, H Li, L Ma, J Zhou, X Guo, SL Woo, Y Pei… - Gastroenterology, 2018 - Elsevier
Background & Aims Transmembrane protein 173 (TMEM173 or STING) signaling by
macrophage activates the type I interferon-mediated innate immune response. The innate …

De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health

L Eissing, T Scherer, K Tödter, U Knippschild… - Nature …, 2013 - nature.com
Clinical interest in de novo lipogenesis has been sparked by recent studies in rodents
demonstrating that de novo lipogenesis specifically in white adipose tissue produces the …

Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity

SL Woo, H Xu, H Li, Y Zhao, X Hu, J Zhao, X Guo… - PloS one, 2014 - journals.plos.org
Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity and insulin
resistance. To better understand the pathophysiology of obesity-associated NAFLD, the …

First genome-wide association study of latent autoimmune diabetes in adults reveals novel insights linking immune and metabolic diabetes

DL Cousminer, E Ahlqvist, R Mishra… - Diabetes …, 2018 - Am Diabetes Assoc
OBJECTIVE Latent autoimmune diabetes in adults (LADA) shares clinical features with both
type 1 and type 2 diabetes; however, there is ongoing debate regarding the precise …

Palmitoleate induces hepatic steatosis but suppresses liver inflammatory response in mice

X Guo, H Li, H Xu, V Halim, W Zhang, H Wang, KT Ong… - PloS one, 2012 - journals.plos.org
The interaction between fat deposition and inflammation during obesity contributes to the
development of non-alcoholic fatty liver disease (NAFLD). The present study examined the …

Berberine ameliorates hepatic steatosis and suppresses liver and adipose tissue inflammation in mice with diet-induced obesity

T Guo, SL Woo, X Guo, H Li, J Zheng, R Botchlett… - Scientific reports, 2016 - nature.com
Increasing evidence demonstrates that berberine (BBR) is beneficial for obesity-associated
non-alcoholic fatty liver disease (NAFLD). However, it remains to be elucidated how BBR …

Bariatric surgery-induced weight loss and associated genome-wide DNA-methylation alterations in obese individuals

FR Talukdar, DI Escobar Marcillo, RS Laskar… - Clinical …, 2022 - Springer
Background Obesity is a multifactorial and chronic condition of growing universal concern. It
has recently been reported that bariatric surgery is a more successful treatment for severe …

The potential utility of PFKFB3 as a therapeutic target

R Bartrons, A Rodríguez-García… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: It has been known for over half a century that tumors exhibit an increased
demand for nutrients to fuel their rapid proliferation. Interest in targeting cancer metabolism …